Viruses and interferon: a fight for supremacy
The DOI matches its Crossref record; 139 of the 139 references it cites were found in a registry or an index.
Abstract
The action of interferons (IFNs) on virus-infected cells and surrounding tissues elicits an antiviral state that is characterized by the expression and antiviral activity of IFN-stimulated genes. In turn, viruses encode mechanisms to counteract the host response and support efficient viral replication, thereby minimizing the therapeutic antiviral power of IFNs. In this review, we discuss the interplay between the IFN system and four medically important and challenging viruses -- influenza, hepatitis C, herpes simplex and vaccinia -- to highlight the diversity of viral strategies. Understanding the complex network of cellular antiviral processes and virus-host interactions should aid in identifying new and common targets for the therapeutic intervention of virus infection. This effort must take advantage of the recent developments in functional genomics, bioinformatics and other emerging technologies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A pivotal study in 1987 reported that a subpopulation of people with viral hepatitis treated with interferon (IFN) α — a pro-inflammatory anti-viral cytokine13 — developed depression14, demonstrating that a pro-inflammatory molecule in the periphery could directly influence mood.”
From Central regulation of stress-evoked peripheral immune responses (2023) · cites this paper as [13]
In the citing paper
“The ISG expression of all monocytes combined and all macrophages combined was higher in HCV infection compared with NS–SS and MASH (Extended Data Fig. 4e), consistent with the role of ISGs as antiviral effectors11.”
In the citing paper
“Neutrophil recruitment is induced mainly by epithelium-derived IL-8/CXCL8, Gro-α/CXCL1, and ENA-78/CXCL5 (142, 178, 223).”
From The airway epithelium: soldier in the fight against respiratory viruses (2011) · cites this paper as [142]
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3
Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129
A comprehensive analysis of protein–protein interactions in Saccharomyces cerevisiae
Uetz, P., Giot, L., Cagney, G., Mansfield, T. A., Judson, R. S., Knight, J. R., Lockshon, D., Narayan, V., Srinivasan, M., Pochart, P., et al. (2000) · Nature · doi:10.1038/35001009 · Cited by 4,706 · cited 1×
“, and to characterize global protein–protein interaction networks in an organis”
BackgroundVirus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Toll-like receptors in the induction of the innate immune response
Aderem, A., & Ulevitch, R. J. (2000) · Nature · doi:10.1038/35021228 · Cited by 3,064
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Antiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743 · cited 1×
“gif" NDATA ITEM> ]> Interferons (IFNs), although best known for their antiviral propertie”
Integrated Genomic and Proteomic Analyses of a Systematically Perturbed Metabolic Network
Ideker, T., Thorsson, V., Ranish, J. A., Christmas, R., Buhler, J., Eng, J. K., Bumgarner, R., Goodlett, D. R., Aebersold, R., & Hood, L. (2001) · Science · doi:10.1126/science.292.5518.929 · Cited by 2,050 · cited 1×
“This confluence of genomic and information technologies brings a powerful new approach to the study of biological systems, as exemplified by recent studie”
BackgroundDer, S. D., Zhou, A., Williams, B. R. G., & Silverman, R. H. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15623 · Cited by 1,816
A N EW A PPROACH TO D ECODING L IFE : Systems Biology
Ideker, T., Galitski, T., & Hood, L. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.343 · Cited by 1,664 · cited 1×
“Together, these technologies provide a global perspective on the complex interactions that occur between all levels of biological information ('systems biology'), from gene expression to protein productio”
Background
Research works printed but not linked: 7
- Biron, C. A. & Sen, G. C. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 321–352 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Witherell, G. W. & Beineke, P. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response. J. Med. Virol. 63, 8–16 (2001). · doi:10.1002/1096-9071(200101)63:1<8::aid-jmv1001>3.0.co;2-k
- Sumpter, R. Jr & Gale, M. Jr. in American Society for Virology 21st Annual Meeting W33-3 (Lexington, Kentucky, 2002).
- Whitley, R. J. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2461–2509 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Roizman, B. & Knipe, D. M. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2399–2460 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Esposito, J. J. & Fenner, F. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2849–2884 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
- Moss, B. in Fields Virology (eds Knipe, D. M. & Howley, P. M.) 2885–2922 (Lippincott, Williams & Wilkins, Philadelphia, 2001).
Cited by
Items 301–400 of 1,000
Zhu, H., & Liu, C. (2003) · Journal of Virology · doi:10.1128/jvi.77.9.5493-5498.2003 · Cited by 102
“At this point in time, antiviral proteins have been characterized only in IFN-induced systems (17, 28).”
BackgroundRecent advances in immunotherapy, immunoadjuvant, and nanomaterial-based combination immunotherapy
Zhou, B., Liu, J., Lin, M., Zhu, J., & Chen, W. R. (2021) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2021.214009 · Cited by 88
Wang, B., Trippler, M., Pei, R., Lu, M., Broering, R., Gerken, G., & Schlaak, J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.06.020 · Cited by 92
“The antiviral state that is induced by IFNs is characterized by the stimulation of IFN-stimulated genes (ISGs) that have antiviral activity [17].”
BackgroundInnate immune activation as a broad-spectrum biodefense strategy
Hackett, C. J. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)02025-6 · Cited by 97
Orvedahl, A., & Levine, B. (2008) · Autophagy · doi:10.4161/auto.5289 · Cited by 87
Kohut, M. L., Sim, Y., Yu, S., Yoon, K. J., & Loiacono, C. M. (2009) · The Journal of Infectious Diseases · doi:10.1086/606014 · Cited by 87
“potent antiviral activity [15] and have more recently”
Derivation and function of small interfering RNAs and microRNAs
Cullen, B. R. (2004) · Virus Research · doi:10.1016/j.virusres.2004.01.009 · Cited by 99
Easton, A. J., Scott, P. D., Edworthy, N. L., Meng, B., Marriott, A. C., & Dimmock, N. J. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.01.102 · Cited by 87
Guo, L., Luo, X., Ren, L., Xu, Y., Zhang, J., Ge, J., Bu, Z., Feng, L., & Wang, Y. (2016) · Journal of Virology · doi:10.1128/jvi.01091-16 · Cited by 97
“Previous reports showed that STAT1 is involved in the upregulation of genes due to signaling by type I or type II interferons (74).”
BackgroundFiloviral Immune Evasion Mechanisms
Ramanan, P., Shabman, R. S., Brown, C. S., Amarasinghe, G. K., Basler, C. F., & Leung, D. W. (2011) · Viruses · doi:10.3390/v3091634 · Cited by 86
“Upon phosphorylation, STAT1/2 dimerize and localize to the nucleus where they activate the transcription of the interferon stimulated genes (ISGs), such as double-stranded RNA-dependent protein kinase (PKR), 2’-5’ oligoadenylate synthetase (OAS), RNAseL, RNA-specific adenosine deaminsases (ADARs), and MHC class 1 and…”
Pathogenesis of acute respiratory illness caused by human parainfluenza viruses
Schomacker, H., Schaap-Nutt, A., Collins, P. L., & Schmidt, A. C. (2012) · Current Opinion in Virology · doi:10.1016/j.coviro.2012.02.001 · Cited by 98
Pregnancy and interferon tau regulate RSAD2 and IFIH1 expression in the ovine uterus
Song, G., Bazer, F. W., & Spencer, T. E. (2007) · Reproduction · doi:10.1530/rep-06-0092 · Cited by 97
“…profiling studies of ruminant endometria (Gray et al. 2006, Klein et al. 2006) as well as knowledge that both RSAD2 and IFIH1 are produced during a viral infection in response to IFNs to limit viral replication and modulate subsequent adaptive immunity (Katze et al. 2002, Helbig et al. 2005).”
BackgroundVollstedt, S., Arnold, S., Schwerdel, C., Franchini, M., Alber, G., Santo, J. P. D., Ackermann, M., & Suter, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.8.3846-3850.2004 · Cited by 86
“The complexity of the “IFN transcriptome” will likely increase when different cell populations are analyzed and global gene expression of organs or even whole organisms can be achieved (24).”
BackgroundZhang, R., Xu, A., Qin, C., Zhang, Q., Chen, S., Lang, Y., Wang, M., Li, C., Feng, W., Zhang, R., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01148-17 · Cited by 92
“Many of the gene products have potent antiviral functions (6, 8, 9).”
BackgroundBVDV: A pestivirus inducing tolerance of the innate immune response
Peterhans, E., & Schweizer, M. (2012) · Biologicals · doi:10.1016/j.biologicals.2012.07.006 · Cited by 103
Regulation of Hepatitis C Virus Replication by Interferon Regulatory Factor 1
Kanazawa, N., Kurosaki, M., Sakamoto, N., Enomoto, N., Itsui, Y., Yamashiro, T., Tanabe, Y., Maekawa, S., Nakagawa, M., Chen, C., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.18.9713-9720.2004 · Cited by 94
“It has been reported that HCV proteins modulate the expression of various IFN-regulated genes (15, 20).”
BackgroundCapitanio, J. P., Abel, K., Mendoza, S. P., Blozis, S. A., McChesney, M. B., Cole, S. W., & Mason, W. A. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2007.05.006 · Cited by 88
Neutrophils—Important Communicators in Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Wirestam, L., Arve-Butler, S., Linge, P., & Bengtsson, A. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02734 · Cited by 92
Chen, Y.-M., Su, Y.-L., Lin, J. H.-Y., Yang, H., & Chen, T.-Y. (2005) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2005.04.001 · Cited by 83
“Search in the transcription factor database (TRANSFAC) reveals that two potential sites involved in the regulation by STAT and NFkB regulator are present in this region [35].”
BackgroundSchweizer, M., Mätzener, P., Pfaffen, G., Stalder, H., & Peterhans, E. (2006) · Journal of Virology · doi:10.1128/jvi.02443-05 · Cited by 95
To Interfere and to Anti-interfere: The Interplay Between Hepatitis C Virus and Interferon
He, Y., & Katze, M. G. (2002) · Viral Immunology · doi:10.1089/088282402317340260 · Cited by 91
Self-citationBoth RIG-I and MDA5 detect alphavirus replication in concentration-dependent mode
Akhrymuk, I. V., Frolov, I. V., & Frolova, E. I. (2015) · Virology · doi:10.1016/j.virol.2015.09.023 · Cited by 94
“The hallmark of the innate immune response is the induction of type I interferons (IFN), which functions both in para- and autocrine modes (Katze et al., 2002; Sen, 2001; Stark et al., 1998).”
BackgroundImproving vaccines by incorporating immunological coadjuvants
Fraser, C. K., Diener, K. R., Brown, M. P., & Hayball, J. D. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.4.559 · Cited by 91
Virtue, E. R., Marsh, G. A., Baker, M. L., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022488 · Cited by 81
“This contrasted with that reported from transfected cells expressing P gene derived proteins [60,61,62,63,64,65].”
ResultPlasmacytoid dendritic cell activation by foot‐and‐mouth disease virus requires immune complexes
Guzylack‐Piriou, L., Bergamin, F., Gerber, M., McCullough, K. C., & Summerfield, A. (2006) · European Journal of Immunology · doi:10.1002/eji.200635866 · Cited by 81
Negorev, D. G., Vladimirova, O. V., Ivanov, A. V., Rauscher, F. J., & Maul, G. G. (2006) · Journal of Virology · doi:10.1128/jvi.02164-05 · Cited by 97
“Viral IE gene expression is decreased in cells pretreated with IFNs (37, 44, 45, 56).”
BackgroundInfluentialThe p38 Mitogen-Activated Protein Kinase Pathway in Interferon Signal Transduction
Katsoulidis, E., Li, Y., Mears, H., & Platanias, L. C. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.749 · Cited by 99
Sumpter, R., Wang, C., Foy, E. M., Loo, Y., & Gale, M. (2004) · Journal of Virology · doi:10.1128/jvi.78.21.11591-11604.2004 · Cited by 81
Self-citationImmunomodulatory Role of Interferons in Viral and Bacterial Infections
Mertowska, P., Smolak, K., Mertowski, S., & Grywalska, E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210115 · Cited by 100
“Understanding the complex cellular network of antiviral processes and virus–host interactions should help identify new targets for therapeutic intervention in viral infection [10].”
BackgroundBaize, S., Pannetier, D., Faure, C., Marianneau, P., Marendat, I., Georges-Courbot, M. C., & Deubel, V. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.02.002 · Cited by 87
The interaction of animal cytoplasmic RNA viruses with the nucleus to facilitate replication
Hiscox, J. A. (2003) · Virus Research · doi:10.1016/s0168-1702(03)00160-6 · Cited by 80
“One of the most obvious effects of virus infection is the induction of the interferon and cytoplasmic RNA viruses have a number of strategies to combat this response (and have recently been reviewed; (Goodbourn et al., 2000; Katze et al., 2002; Young et al., 2000)).”
Rakus, K. Ł., Irnazarow, I., Adamek, M., Palmeira, L., Kawana, Y., Hırono, I., Kondo, H., Matras, M., Steinhagen, D., Flasz, B., et al. (2011) · Developmental & Comparative Immunology · doi:10.1016/j.dci.2011.12.006 · Cited by 87
“The antiviral effect is exerted through the binding of type I IFNs to specific cell-surface receptors and triggering signal transduction through the JAK-STAT signal transduction pathway, which in-turn induces the expression of a large number of IFN-stimulated genes, some of which encode antiviral proteins (Katze et al…”
BackgroundMcBeath, A., Collet, B., Paley, R. K., Duraffour, S., Aspehaug, V. T., Biering, E., Secombes, C. J., & Snow, M. (2005) · Virus Research · doi:10.1016/j.virusres.2005.08.005 · Cited by 85
The viral RNase Erns prevents IFN type-I triggering by pestiviral single- and double-stranded RNAs
Mätzener, P., Magkouras, I., Rümenapf, T., Peterhans, E., & Schweizer, M. (2008) · Virus Research · doi:10.1016/j.virusres.2008.10.015 · Cited by 91
Wang, S., Chi, X., Wei, H., Chen, Y., Chen, Z., Huang, S., & Chen, J. (2014) · Journal of Virology · doi:10.1128/jvi.00126-14 · Cited by 82
Lin, K. W., Kwong, A. D., & Lin, C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4784-4792.2004 · Cited by 79
“In addition, agents such as IFNand ribavirin could exert indirect antiviral activities, such as immunomodulatory effects, that are absent in the in vitro system (15, 20, 26, 32).”
BackgroundNakatsu, Y., Takeda, M., Ohno, S., Koga, R., & Yanagi, Y. (2006) · Journal of Virology · doi:10.1128/jvi.00751-06 · Cited by 82
“Phosphorylated Stats activate the transcription of specific genes, referred to as IFN-stimulated genes, containing an IFN-stimulated response element in their transcriptional enhancer sequences (28).”
BackgroundInfluentialRNA Dimerization Promotes PKR Dimerization and Activation
Heinicke, L. A., Wong, C. J., Lary, J. W., Nallagatla, S. R., Diegelman‐Parente, A., Zheng, X., Cole, J. L., & Bevilacqua, P. C. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.05.005 · Cited by 80
Sáinz, B., LaMarca, H. L., Garry, R. F., & Morris, C. A. (2005) · Virology Journal · doi:10.1186/1743-422x-2-14 · Cited by 81
“Although IFNs are effective inhibitors of viruses such as vesicular stomatitis virus and encephalomyocarditis virus [26], almost all RNA and DNA viruses have evolved mechanisms to subvert the host IFN response [21,26,27].”
Activation of the Innate Immune Response against DENV in Normal Non-Transformed Human Fibroblasts
Bustos‐Arriaga, J., García‐Machorro, J., León‐Juárez, M., García‐Cordero, J., Santos‐Argumedo, L., Flores‐Romo, L., Méndez‐Cruz, A. R., Juárez-Delgado, F. J., & Cedillo‐Barrón, L. (2011) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0001420 · Cited by 82
“The induction of type I interferon (IFNa/b) is an early protective event that occurs within hours of viral infection and is widely accepted as one of the most immediate and important antiviral host response [34]; therefore, we investigated whether human skin fibroblasts produce IFNb upon infection with DENV-2.”
BackgroundEGFR kinase activity is required for TLR4 signaling and the septic shock response
Chattopadhyay, S., Veleeparambil, M., Poddar, D., Abdulkhalek, S., Bandyopadhyay, S. K., Fensterl, V., & Sen, G. C. (2015) · EMBO Reports · doi:10.15252/embr.201540337 · Cited by 84
“The activated transcription factors translocate to the nucleus and induce transcription of cytokines and other antimicrobial genes [8].”
Meerts, P., Misinzo, G., & Nauwynck, H. (2005) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2005.25.684 · Cited by 77
“(24,25) Other cytokines, however, such as TNF-(cid:2) , can influence the evolution of an infection.”
Su, Q., Wang, S., Baltzis, D., Qu, L.-K., Wong, A. H.-T., & Koromilas, A. E. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0508207103 · Cited by 76
Solis, M., Goubau, D., Romieu, R., Génin, P., Civas, A., & Hiscott, J. B. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.06.002 · Cited by 82
Type I Interferon Controls Propagation of Long Interspersed Element-1
Yu, Q., Carbone, C. J., Katlinskaya, Y. V., Zheng, H., Zheng, K., Luo, M., Wang, P. J., Greenberg, R. A., & Fuchs, S. Y. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.612374 · Cited by 76
“It is worth noting that the current paradigm highlights numerous mechanisms by which viruses limit the stimulation of IFN production or inhibit IFN signaling thus allowing propagation of these viruses (1, 36).”
BackgroundPannetier, D., Faure, C., Georges-Courbot, M. C., Deubel, V., & Baize, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10516-10524.2004 · Cited by 76
“IFN- is well known for its major antiviral properties (20, 31).”
BackgroundAmbagala, A. P. N., & Cohen, J. I. (2007) · Journal of Virology · doi:10.1128/jvi.00325-07 · Cited by 76
“Type I IFNs exert their effects in target cells by inducing expression of a large number of IFN-stimulated genes (27).”
BackgroundLocal scaffold-assisted delivery of immunotherapeutic agents for improved cancer immunotherapy
Shang, Q., Dong, Y., Su, Y., Leslie, F., Sun, M., & Wang, F. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114308 · Cited by 76
Lin, R., Yang, L., Arguello, M., Penafuerte, C., & Hiscott, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408452200 · Cited by 74
Suppression of the Interferon-Mediated Innate Immune Response by Pseudorabies Virus
Brukman, A., & Enquist, L. W. (2006) · Journal of Virology · doi:10.1128/jvi.00554-06 · Cited by 80
Parsons, K. S., Hsu, A., & Wark, P. A. B. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12218 · Cited by 75
DeFilippis, V. R., Robinson, B. A., Keck, T. M., Hansen, S. G., Nelson, J. A., & Früh, K. (2005) · Journal of Virology · doi:10.1128/jvi.80.2.1032-1037.2006 · Cited by 91
“To independently confirm the IRF3 dependence of ISG induction, we employed a dominant negative form of IRF3 (IRF3- N) from which the DNA binding domain was removed (10).”
MethodModulation of the Immune System by Human Rhinoviruses
Kirchberger, S., Majdic, O., & Stöckl, J. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000095993 · Cited by 82
“A typical antiviral immune response is a combination of innate and adaptive immunity. Type-I interferons (IFN) are known as the prototypic and early mediators of an innate antiviral immune response [”
BackgroundDessouki, O., Kamiya, Y., Nagahama, H., Tanaka, M., Suzu, S., Sasaki, Y., & Okada, S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.008 · Cited by 74
Early bovine embryos regulate oviduct epithelial cell gene expression during in vitro co-culture
Schmaltz-Panneau, B., Cordova, A., Dhorne‐Pollet, S., Hennequet‐Antier, C., Uzbekova, S., Martinot, E., Doret, S., Martin, P., Mermillod, P., & Locatelli, Y. (2014) · Animal Reproduction Science · doi:10.1016/j.anireprosci.2014.06.022 · Cited by 77
“RSAD2 is a cytoplasmic protein produced during viral infection in order to limit viral replication and to modulate subsequent adaptive immunity (Katze et al., 2002).”
BackgroundKleymann, G. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.2.135 · Cited by 74
“IL-2, -12, INF-α and -γ play a major role during the control of an HSV infection by the immune system [28,29,36-40].”
BackgroundLiu, X., Sadaoka, T., Krogmann, T. A., & Cohen, J. I. (2020) · Journal of Virology · doi:10.1128/jvi.00258-20 · Cited by 82
Barros, M. H. M., Segges, P., Vera‐Lozada, G., Hassan, R., & Niedobitek, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124531 · Cited by 79
“Induction of expression and phosphorylation of STAT1 transcription factor is a well-described early event in macrophage polarization in a Th1-dominant microenvironment [12,19,20].”
BackgroundSeo, Y., Blake, C., Alexander, S., & Hahm, B. (2010) · Journal of Virology · doi:10.1128/jvi.00510-10 · Cited by 76
“Interestingly, influenza virus infection of SPL cells induced early activation of STAT1/2 signaling, which is known as a powerful host defense mechanism against influenza virus infection (16, 18, 22, 40).”
BackgroundLi, L., Wei, Z., Zhou, Y., Gao, F., Jiang, Y., Yu, L., Zheng, H., Tong, W., Yang, S., Zheng, H., et al. (2014) · Virus Research · doi:10.1016/j.virusres.2014.08.012 · Cited by 76
“Type I interferons can initiate the activation of JAK/STAT signaling to induce the expression of hundreds of IFN-stimulated genes (ISGs), which play an important role in antiviral activities (Albina et al., 1998; Katze et al., 2002; Overend et al., 2007) .”
BackgroundInnate immune response to viral infection of the lungs
See, H., & Wark, P. (2008) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2008.04.001 · Cited by 72
“Infected cells also generate enzymes RNAse-I and 20,5000 oligoadenylate synthetase that degrade viral RNA and prevent replication.(44) Myxovirus resistance proteins are induced by IFNs and are important in inhibiting replication of influenza viruses.”
BackgroundInfluentialChan, L. L. Y., Cheung, B. K. W., Li, J., & Lau, A. S. Y. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1009659 · Cited by 83
“pathway [11, 12].”
A-to-G Hypermutation in the Genome of Lymphocytic Choriomeningitis Virus
Zahn, R. C., Schelp, I., Utermöhlen, O., & von Laer, D. (2006) · Journal of Virology · doi:10.1128/jvi.00067-06 · Cited by 80
“IFN- and IFN- bind to their receptors and thereby induce an auto- and paracrine stimulation of antiviral enzymes and proteins, such as the RNA-dependent protein kinase (PKR), 2-5A-dependent RNase (RNase L), and 2 -5 oligoadenylate synthetase (OAS) (17, 31).”
BackgroundSystem-based proteomic analysis of the interferon response in human liver cells
Yan, W., Lee, H., Yi, E. C., Reiss, D., Shannon, P., Kwieciszewski, B. K., Coito, C., Li, X.-J., Keller, A., Eng, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-8-r54 · Cited by 72
“%) encoding the IFNinduced proteins contain at least one cis-element of the ISRE, GAS, IRF-3 or IRF-7 binding sites, suggesting possible direct transcriptional regulation of these proteins.”
BackgroundSelf-citationWang, C., Sun, M., Yuan, X., Ji, L., Jin, Y., Cardona, C. J., & Xing, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.745729 · Cited by 77
“Accumulated evidence shows that viral infections can circumvent the IFN response by either suppressing IFN induction or blocking IFN stimulation to induce ISGs (6-9).”
BackgroundPestiviruses: How to outmaneuver your hosts
Peterhans, E., & Schweizer, M. (2009) · Veterinary Microbiology · doi:10.1016/j.vetmic.2009.09.038 · Cited by 92
Evolution of the interferon alpha gene family in eutherian mammals
Woelk, C. H., Frost, S. D. W., Richman, D. D., Higley, P. E., & Pond, S. L. K. (2007) · Gene · doi:10.1016/j.gene.2007.03.018 · Cited by 82
Case, J. B., Ashbrook, A. W., Dermody, T. S., & Denison, M. R. (2016) · Journal of Virology · doi:10.1128/jvi.00542-16 · Cited by 79
Interferon Beta: From Molecular Level to Therapeutic Effects
Abdolvahab, M. H., Mofrad, M. R. K., & Schellekens, H. (2016) · International review of cytology · doi:10.1016/bs.ircmb.2016.06.001 · Cited by 81
Ras-dependent oncolysis with an adenovirus VAI mutant.
Cascalló, M., Capellá, G., Mazo, A., & Alemany, R. (2003) · PubMed · Cited by 88
Kell, D. B., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220154 · Cited by 82
Lobigs, M., Müllbacher, A., & Regner, M. (2003) · Immunology and Cell Biology · doi:10.1046/j.1440-1711.2003.01161.x · Cited by 74
Hepatocytes demarcated by EphB2 contribute to the progression of nonalcoholic steatohepatitis
Xiao, Y., Batmanov, K., Hu, W., Zhu, K., Tom, A. Y., Guan, D., Jiang, C., Cheng, L., McCright, S. J., Yang, E. C., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.adc9653 · Cited by 69
Tumor necrosis factor and interferon: cytokines in harmony
Bartee, E., Mohamed, M. R., & McFadden, G. (2008) · Current Opinion in Microbiology · doi:10.1016/j.mib.2008.05.015 · Cited by 69
“Although IFNs alone are effective inhibitors of some viruses, such as vesicular stomatitis virus (VSV) or encephalomyocarditis virus (EMCV), many other viruses have evolved sophisticated mechanisms to subvert the host IFN responses [1] [2] [3] .”
Peyrefitte, C. N., Perret, M., Garcia, S., Rodrigues, R., Bagnaud, A., Lacôte, S., Crance, J., Vernet, G., Garín, D., Bouloy, M., et al. (2009) · Journal of General Virology · doi:10.1099/vir.0.015701-0 · Cited by 69
“To analyse essential elements of the innate immunity elicited in response to virus infection (Katze et al., 2002), we investigated whether IFN-a and IFN-b were expressed by the in vitro-infected APCs.”
BackgroundRacicot, K. E., Kwon, J., Aldo, P. B., Abrahams, V. M., El-Guindy, A. S., Romero, R. J., & Mor, G. (2016) · American Journal of Reproductive Immunology · doi:10.1111/aji.12501 · Cited by 72
García‐Sastre, A. (2004) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06099-5_7 · Cited by 84
SAR-Based Optimization of a 4-Quinoline Carboxylic Acid Analogue with Potent Antiviral Activity
Das, P., Deng, X., Zhang, L., Roth, M. G., Fontoura, B. M. A., Phillips, M. A., & Brabander, J. K. D. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300464h · Cited by 77
Sui, H., Zhao, G., Huang, J., Jin, D., Yuen, K., & Zheng, B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005671 · Cited by 72
“A possible explanation is that some double stranded siRNAs may result in IFN responses or activate a RNA degradation pathway, e.g. Phosphorylated protein Kinase R (PKR) [9,31,32].”
Development of antiviral therapy for severe acute respiratory syndrome
CINATLJR, J., Michaelis, M., Hoever, G., Preiser, W., & Doerr, H. W. (2005) · Antiviral Research · doi:10.1016/j.antiviral.2005.03.002 · Cited by 80
“IFNs consist of the multiple type I species (IFN- , IFN- , IFN, and IFN- ), and the one type II species (IFN- ), both of which have antiviral activity (Sen, 2001; Katze et al., 2002; Urosevic, 2003).”
Acharjee, S., Noorbakhsh, F., Stemkowski, P. L., Olechowski, C., Cohen, É. A., Ballanyi, K., Kerr, B. J., Pardo, C. A., Smith, P. A., & Power, C. (2010) · The FASEB Journal · doi:10.1096/fj.10-162313 · Cited by 68
Wu, X., Wang, J., Wang, S., Wu, F., Chen, Z., Li, C., Cheng, G., & Qin, F. X.-F. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00344 · Cited by 72
“Type I IFNs subsequently induce the expression of a battery of downstream genes broadly known as IFN-stimulated genes (ISGs) which leads to an antiviral state effectively blocking viral replication (Katze et al., 2002; Pestka et al., 2004; Sadler and Williams, 2008; Shapira et al., 2009; GarciaSastre, 2011; Pothlichet…”
BackgroundAutoimmunity as the comet tail of COVID-19 pandemic
Talotta, R., & Robertson, E. S. (2020) · World Journal of Clinical Cases · doi:10.12998/wjcc.v8.i17.3621 · Cited by 76
Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis
Liang, C., Lee, J., & Jung, J. U. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.09.003 · Cited by 72
Bou‐Nader, C., Gordon, J. M., Henderson, F. E., & Zhang, J. (2019) · RNA · doi:10.1261/rna.070169.118 · Cited by 69
“Notably, this region of IFN-γ mRNA also contains the first 26 translated codons, invoking structural rearrangements for its dual function: translation or PKR activation.”
BackgroundInfluentialInteraction of viruses with the mammalian RNA interference pathway
Schütz, S., & Sarnow, P. (2005) · Virology · doi:10.1016/j.virol.2005.09.034 · Cited by 77
“…because of the ubiquity and effectiveness of the interferon system which responds to the accumulation of viral double-stranded RNAs by inducing the synthesis of a large group of genes which exert inhibitory effects on viral gene expression (reviewed in (Gale et al., 2000; Katze et al., 2002).”
BackgroundHost and viral factors in the immunopathogenesis of primary hepatitis C virus infection
Lloyd, A. R., Jagger, E., Post, J. J., Crooks, L., Rawlinson, W. D., Hahn, Y. S., & Ffrench, R. A. (2006) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100010 · Cited by 78
Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors
Lopez-Gordo, E., Podgorski, I. I., Downes, N., & Alemany, R. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.228 · Cited by 65
“uninfected cells recognize IFN by IFN receptors and they induce, via the Jak-STAT signaling pathway, the expression of antiviral enzymes such as MxA, 2¢,5¢-oligoadenylate synthase, and protein kinase R (Katze et al., 2002).”
Liao, Y., Wang, X., Huang, M., Tam, J. P., & Liu, D. X. (2011) · Virology · doi:10.1016/j.virol.2011.09.003 · Cited by 65
Pegylated interferons α2a and α2b in the treatment of chronic hepatitis C
Aghemo, A., Rumi, M. G., & Colombo, M. G. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.101 · Cited by 72
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus†
Dharel, N., Kato, N., Muroyama, R., Taniguchi, H., Otsuka, M., Wang, Y., Jazag, A., Shao, R., Chang, J., Adler, M. K., et al. (2008) · Hepatology · doi:10.1002/hep.22176 · Cited by 65
Hepatitis C Infection and Alcohol Use: A Dangerous Mix for the Liver and Antiviral Immunity
Szabo, G., Aloman, C., Polyak, S. J., Weinman, S. A., Wands, J., & Zakhari, S. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00083.x · Cited by 64
Long non-coding RNA ANRIL in gene regulation and its duality in atherosclerosis
Chi, J., Li, J.-Z., Jia, J., Zhang, T., Liu, X.-M., & Yi, L. (2017) · Current Medical Science · doi:10.1007/s11596-017-1812-y · Cited by 72
PKR in Innate Immunity, Cancer, and Viral Oncolysis
Balachandran, S., & Barber, G. N. (2007) · Cancer Genomics and Proteomics · doi:10.1007/978-1-59745-335-6_18 · Cited by 65
Regulation of Chemokine mRNA Stability by Lipopolysaccharide and IL-10
Biswas, R., Datta, S., Gupta, J. D., Novotny, M., Tebo, J., & Hamilton, T. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.12.6202 · Cited by 65
Oncolytic measles viruses for cancer therapy
Nakamura, T., & Russell, S. J. (2004) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.4.10.1685 · Cited by 65
“As the next step after infection, the primary innate response of a virally infected cell is to inhibit viral protein synthesis, a response that is coordinated through the double-stranded RNA-dependent protein kinase (PKR) and IFN-α/β [24].”
BackgroundBanerjee, A., El-Sayes, N., Budylowski, P., Jacob, R. A., Richard, D. J., Maan, H., Aguiar, J. A., Demian, W. L. L., Baid, K., D’Agostino, M. R., et al. (2021) · iScience · doi:10.1016/j.isci.2021.102477 · Cited by 72
“Type I IFN production is primarily mediated by the phosphorylation and activation of TBK1, which in turn phosphorylates and activates IRF3 (Janeway and Medzhitov, 2002; Kawai and Akira, 2006).”
Lan, K., Lan, K.-L., Lee, W.-P., Sheu, M., Chen, M., Lee, Y.-L., Yen, S., Chang, F., & Lee, S. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.11.013 · Cited by 79
Cheng, M., Si, Y., Niu, Y., Liu, X., Li, X., Zhao, J., Jin, Q., & Yang, W. Z. (2013) · Journal of Virology · doi:10.1128/jvi.00802-13 · Cited by 64
“Several type I IFN-regulated gene products, such as protein kinase R, the 2=-5= oligoadenylate synthetase/ RNase L system, the adenosine deaminase ADAR1, and the Mx GTPases, are important effectors of these cytokines’ antiviral properties (8).”
BackgroundStoltz, M., & Klingström, J. (2010) · Journal of Virology · doi:10.1128/jvi.00717-10 · Cited by 64
“In an autocrine as well as a paracrine fashion, secreted IFN- / activates expression of IFN-stimulated genes (ISGs) that, in turn, induce an antiviral state, thereby inhibiting viral replication and dissemination (8, 16, 34).”
BackgroundResult
Metadata
- Authors
- Katze, M. G., He, Y., & Gale, M.
- Affiliations
- University of Washington (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Katze, Michael G.
- Venue
- Nature Reviews Immunology
- Published
- 2002-09-01
- Volume
- 2
- Issue
- 9
- Pages
- 675-687
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2079295092
- Cited by
- 1,419
- References
- 138
- Citations by year
- 2026: 30 · 2025: 62 · 2024: 89 · 2023: 82 · 2022: 67 · 2021: 48 · 2020: 35 · 2019: 30 · 2018: 23 · 2017: 38 · 2016: 41 · 2015: 40 · 2014: 55 · 2013: 58 · 2012: 55
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- interferon, antiviral immunity, host-virus interaction, interferon-stimulated genes, viral evasion of host defense, influenza virus, hepatitis C virus, herpes simplex virus, vaccinia virus, antiviral drug targets
- MeSH terms
- Animals, Hepatitis C, Herpes Simplex, Humans, Interferon Type I, Membrane Glycoproteins, Orthomyxoviridae, Orthomyxoviridae Infections, Receptors, Cell Surface, Vaccinia, Vaccinia virus, Virus Diseases, Virus Replication, Hepacivirus, Simplexvirus, Computational Biology, Databases as Topic, Genomics, Drosophila Proteins, Toll-Like Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.